Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTLX
āļāļ·āđāļāļāļĢāļīāļĐāļąāļTelix Pharmaceuticals Ltd
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 15, 2017
āļāļĩāļāļĩāđāļOrtiz (Raphaeel)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ- -
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļ- -
āļāļĩāđāļāļĒāļđāđ55 Flemington Road
āđāļĄāļ·āļāļMELBOURNE
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻAustralia
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ3051
āđāļāļĢāļĻāļąāļāļāđ61390933855
āđāļ§āđāļāđāļāļāđhttps://telixpharma.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTLX
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļNov 15, 2017
āļāļĩāļāļĩāđāļOrtiz (Raphaeel)
Dr. Darren Patti, Pharm.D.
Dr. Darren Patti, Pharm.D.
Group Chief Operating Officer
Group Chief Operating Officer
Ms. Lena Moran-Adams
Group General Counsel
Mr. Marcin Firek
Company Secretary
Mr. William (Bill) Jellison
Mr. William (Bill) Jellison
Additional Non-Executive Director
Additional Non-Executive Director
Dr. Maria Rivas, M.D.
Additional Non-Executive Director
Additional Non-Executive Director
Ms. Shomalin Naidoo
Interim Company Secretary
Interim Company Secretary
Mr. David Gill
Non-Executive Chair of the Board
Non-Executive Chair of the Board
Dr. Paul Schaffer
Chief Technology Officer
Ms. Marie McDonald
Independent Non-Executive Director
Independent Non-Executive Director
Mr. James Stonecypher
Group Chief Development Officer
Group Chief Development Officer
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Dr. Darren Patti, Pharm.D.
Dr. Darren Patti, Pharm.D.
Group Chief Operating Officer
Group Chief Operating Officer
Ms. Lena Moran-Adams
Group General Counsel
Mr. Marcin Firek
Company Secretary
Mr. William (Bill) Jellison
Mr. William (Bill) Jellison
Additional Non-Executive Director
Additional Non-Executive Director
Dr. Maria Rivas, M.D.
Additional Non-Executive Director
Additional Non-Executive Director
Ms. Shomalin Naidoo
Interim Company Secretary
Interim Company Secretary